Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

GermanyBack to Germany

Clinical trials in Simmern

8 clinical trials in Simmern, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.

GermanyOur site in GermanyKlinischeStudien.de(opens in a new tab)
Simmern at a glance
8
clinical trials
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

8 trials in Simmern

Open in trial search

Actinic keratosis

Recruiting

Study on the Effectiveness of 5% Potassium Hydroxide Solution for Treating Mild to Moderate Actinic Keratosis in Adults

Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Potassium hydroxide
  • Sponsor:INFECTOPHARM Arzneimittel und Consilium GmbH

Osteoarthritis

Recruiting

Study on Shortened Anticoagulation with Rivaroxaban for Blood Clot Prevention in Patients Undergoing Hip Replacement Surgery

Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Rivaroxaban
  • Sponsor:Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz KöR

Dermatitis atopic

Recruiting

Study Comparing Methylprednisolone Aceponate Creams and a Non-Active Cream for Patients with Mild to Moderate Atopic Dermatitis

Registered drug
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Methylprednisolone Aceponate
  • Sponsor:Dermapharm AG

Acarodermatitis

Recruiting

Study on Treating Scabies with Permethrin and Ivermectin for Patients with Scabies

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Ivermectin
  • Sponsor:INFECTOPHARM Arzneimittel und Consilium GmbH

Hidradenitis

Not recruiting

Study on the Effectiveness of IC0624 for Patients with Mild to Moderate Hidradenitis Suppurativa

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years
  • Substances:Sodium bituminosulfonate dry substance
  • Sponsor:Ichthyol-Gesellschaft Cordes Hermanni & Co. GmbH & Co. KG

Dermatitis atopic

Not recruiting

Study of Upadacitinib and Topical Corticosteroids for Adolescents and Adults with Moderate to Severe Eczema

Registered drug
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Hydrocortisone
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Dermatitis atopic

Not recruiting

Study of Upadacitinib for Adolescents and Adults with Moderate to Severe Eczema

Investigational
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Upadacitinib
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Psoriasis

Not recruiting

Study on the Effectiveness and Safety of HRO350 for Patients with Mild-to-Moderate Psoriasis

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Pehero
  • Sponsor:Arctic Bioscience AS

Other cities in Germany

The busiest research cities in the country

All 513 cities in Germany

Clinical research in Simmern

What the registry says about research in the country

01 Inflammatory Skin Conditions

Groundbreaking research focusing on atopic dermatitis treatments, including studies evaluating new combination therapies with topical corticosteroids and innovative systemic treatments.

  • Moderate to Severe Eczema Management
  • Novel Treatment Combinations
  • Long-term Efficacy Studies

Multiple clinical trials are examining both established and experimental therapies for varying severities of atopic conditions.

02 Chronic Skin Disorders

Innovative research targeting psoriasis and hidradenitis suppurativa, exploring new oral medications and investigating first-line therapeutic options for patients.

  • Mild to Moderate Psoriasis Treatment
  • Novel Therapeutic Compounds
  • Active Disease Management

These trials aim to expand treatment options and improve patient outcomes in chronic skin conditions.

03 Dermatological Infections

Critical studies addressing scabies treatment protocols and evaluating new approaches for actinic keratosis management through controlled clinical trials.

  • Topical Treatment Efficacy
  • Comparative Treatment Studies
  • Therapeutic Solutions

Research focuses on optimizing treatment durations and comparing various therapeutic approaches for skin infections and lesions.

Back to GermanyAll countries
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.